form8k012313.htm
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported):
January 23, 2013

 
MERIDIAN BIOSCIENCE, INC.
(Exact name of registrant as specified in its charter)

Ohio
  
0-14902
  
31-0888197
(State or other jurisdiction of incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No. )

 
 
3471 River Hills Drive, Cincinnati, Ohio
  
45244
(Address of principal executive offices)
  
(Zip Code)

 
Registrant’s telephone number, including area code
  
(513) 271-3700

 
 
(Former name or former address, if changed since last report.)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 
 
 
 

Item 2.02  Results of Operations and Financial Condition.
 
On January 23, 2013, the Company issued a press release announcing its financial results for the fiscal quarter ended December 31, 2012.  A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
 
Item 5.07  Submission of Matters to a Vote of Security Holders.
 
The following matters were submitted to a vote of shareholders at the Company's Annual Meeting of Shareholders, which was held on January 23, 2013:
 
(a)  Votes regarding the election of five directors:
 

Name
For
Withheld
Broker Non-Votes
James M. Anderson
32,089,516
  2,123,708  
4,919,729
John A. Kraeutler
33,411,621
  801,603  
4,919,729
William J. Motto
26,443,099
  7,770,125  
4,919,729
David C. Phillips
32,078,628
  2,134,596  
4,919,729
Robert J. Ready
32,080,242
   2,132,982  
4,919,729

 
(b)  Advisory Votes regarding named executive officer compensation:
 

For
Against
Abstain
  Broker Non-Votes
  27,705,785   5,881,588   625,851  4,919,729
 
 
(c)  Votes regarding the ratification of the Audit Committee’s appointment of Grant Thornton LLP as Meridian’s Independent Registered Public Accounting Firm for fiscal 2013:
 
For
Against
Abstain
 36,074,369  2,622,883  435,701

 
Item 9.01  Financial Statements and Exhibits.
 
(d)           Exhibits
 
       99.1
Press Release dated January 23, 2013.
 
 

 
 
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MERIDIAN BIOSCIENCE, INC.
 
 
  
       
Date:  January 24, 2013
By:
/s/  Melissa A. Lueke  
    Melissa A. Lueke  
   
Executive Vice President and
Chief Financial Officer
  
    (Principal Accounting Officer)